ENALARE THERAPEUTICS, INC.

Lobbying Spend

—

Filings

Firms Hired

Active Period

2021–2023

Lobbying Spend by Year

Client-reported lobbying expenses on LDA filings

Year	Lobbying Spend	Filings	Firms
2023	—	2	1
2022	—	4	1
2021	—	2	1

Lobbying firms retained by this client; amounts are client-reported expenses when available

Firm Name	Reported Spend	Filings
AMERICAN DEFENSE INTERNATIONAL INC	—	8

Government entities explicitly identified as targets in LDA filings

Most frequently reported lobbying issues

Issue Code	Description	Reports
Defense	Defense	5

Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded

H.R. 7900117th Congress

National Defense Authorization Act for Fiscal Year 2023

Cited source text and reported amounts

HR 7900 National Defense Authorization Act for FY23, provision relating to respiratory stimulants.

Client expense: — · Firm income: —

Matched citations: HR 7900

H.R. 7900117th Congress

National Defense Authorization Act for Fiscal Year 2023

Cited source text and reported amounts

HR 7900 National Defene Authorization Act for FY23, proviion relating to respiratory stimulants.

Client expense: — · Firm income: —

Matched citations: HR 7900

ENALARE THERAPEUTICS, INC. — Lobbying Disclosure | Poliscope